--- title: Latest News | Hemostemix (5) description: Company news for investors and health professionals (5) --- [![Hemostemix Logos](https://hemostemix.com/hubfs/Hemostemix%20Logos.png)](https://hemostemix.com) - [Patient Information](https://hemostemix.com/investigational-treatment-options) - [Physician Information](https://hemostemix.com/physicians) - ACP-01 Show submenu for ACP-01 - [ACP-01](https://hemostemix.com/acp-autologous-stem-cell-therapy) - [Clinical Research](https://hemostemix.com/clinical-research) - Conditions Show submenu for Conditions - [Cardiovascular Ischemia & Angina](https://hemostemix.com/cardiovascular-ischemia-angina) - [Chronic Limb Ischemia - CLTI](https://hemostemix.com/chronic-limb-threatening-ischemia) - [Peripheral Arterial Disease- PAD](https://hemostemix.com/peripheral-arterial-disease-pad-and-peripheral-ischemia) - [Vascular Dementia](https://hemostemix.com/vascular-dementia) - [Wound Care](https://hemostemix.com/wound-care) - Blog Show submenu for Blog - [Hemostemix Health Hub](https://hemostemix.com/health-hub-blog) - [Hemostemix Video Library](https://hemostemix.com/videolibrary) - [About](https://hemostemix.com/about) - [Patient Information](https://hemostemix.com/investigational-treatment-options) - [Physician Information](https://hemostemix.com/physicians) - ACP-01 Show submenu for ACP-01 - [ACP-01](https://hemostemix.com/acp-autologous-stem-cell-therapy) - [Clinical Research](https://hemostemix.com/clinical-research) - Conditions Show submenu for Conditions - [Cardiovascular Ischemia & Angina](https://hemostemix.com/cardiovascular-ischemia-angina) - [Chronic Limb Ischemia - CLTI](https://hemostemix.com/chronic-limb-threatening-ischemia) - [Peripheral Arterial Disease- PAD](https://hemostemix.com/peripheral-arterial-disease-pad-and-peripheral-ischemia) - [Vascular Dementia](https://hemostemix.com/vascular-dementia) - [Wound Care](https://hemostemix.com/wound-care) - Blog Show submenu for Blog - [Hemostemix Health Hub](https://hemostemix.com/health-hub-blog) - [Hemostemix Video Library](https://hemostemix.com/videolibrary) - [About](https://hemostemix.com/about) ![menu](https://f.hubspotusercontent40.net/hubfs/7479797/menu.png) ![close\_24px](https://7479797.fs1.hubspotusercontent-na1.net/hubfs/7479797/close_24px.svg) [Investor Site](https://investors.hemostemix.com/) ![](https://hemostemix.com/hubfs/Old%20Site%20Files/sublogo.png) ### Hemostemix All Post - [All Post](https://hemostemix.com/latest-news) - [Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations) - [Latest News](https://hemostemix.com/latest-news/tag/latest-news) - [Chronic Limb Threatening Ischemia](https://hemostemix.com/latest-news/tag/chronic-limb-threatening-ischemia) - [Uncategorized](https://hemostemix.com/latest-news/tag/uncategorized) - [Angina](https://hemostemix.com/latest-news/tag/angina) - [Stem Cells](https://hemostemix.com/latest-news/tag/stem-cells) - [Vascular Dementia](https://hemostemix.com/latest-news/tag/vascular-dementia) - Wound Care Search ###### [Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office](https://hemostemix.com/latest-news/hemostemix-your-fountain-of-youth-trademark-granted-by-japan-patent-office) [Read More](https://hemostemix.com/latest-news/hemostemix-your-fountain-of-youth-trademark-granted-by-japan-patent-office) ###### [Hemostemix Announces Engagement of Oak Hill Asset Management Inc.](https://hemostemix.com/latest-news/hemostemix-announces-engagement-of-oak-hill-asset-management-inc) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-engagement-of-oak-hill-asset-management-inc) ###### [Hemostemix’s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial](https://hemostemix.com/latest-news/hemostemixs-pitch-to-wall-street-acp-01-vascular-dementia-trial-will-generate-5365000-capture-data-as-a-phase-1-clinical-trial) [Read More](https://hemostemix.com/latest-news/hemostemixs-pitch-to-wall-street-acp-01-vascular-dementia-trial-will-generate-5365000-capture-data-as-a-phase-1-clinical-trial) ###### [Hemostemix Unit Offering Repriced](https://hemostemix.com/latest-news/hemostemix-unit-offering-repriced) [Read More](https://hemostemix.com/latest-news/hemostemix-unit-offering-repriced) ###### [Hemostemix Announces Unit Private Placement](https://hemostemix.com/latest-news/hemostemix-announces-unit-private-placement) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-unit-private-placement) ###### [Hemostemix Closes $403,539 of the Unit Private Placement](https://hemostemix.com/latest-news/hemostemix-closes-403539-of-the-unit-private-placement) [Read More](https://hemostemix.com/latest-news/hemostemix-closes-403539-of-the-unit-private-placement) ###### [Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company](https://hemostemix.com/latest-news/hemostemix-precerv-inc-retains-chris-mcnorgan-phd-to-license-ncp-01-to-neural-electrode-brain-implant-company-2) [Read More](https://hemostemix.com/latest-news/hemostemix-precerv-inc-retains-chris-mcnorgan-phd-to-license-ncp-01-to-neural-electrode-brain-implant-company-2) ###### [Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund up to 75% of 5-Year Costs](https://hemostemix.com/latest-news/hemostemix-hiring-4-new-biotechnologists-in-montreal-and-appling-for-grants-to-fund-up-to-75-of-5-year-costs) [Read More](https://hemostemix.com/latest-news/hemostemix-hiring-4-new-biotechnologists-in-montreal-and-appling-for-grants-to-fund-up-to-75-of-5-year-costs) ###### [Hemostemix Announces its AI Strategy](https://hemostemix.com/latest-news/hemostemix-announces-its-ai-strategy) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-its-ai-strategy) ###### [Hemostemix’s Private Placement Use of Proceeds](https://hemostemix.com/latest-news/hemostemixs-private-placement-use-of-proceeds) [Read More](https://hemostemix.com/latest-news/hemostemixs-private-placement-use-of-proceeds) [3](https://hemostemix.com/latest-news/author/admin/page/3) [4](https://hemostemix.com/latest-news/author/admin/page/4) [5](https://hemostemix.com/latest-news/author/admin/page/5) [6](https://hemostemix.com/latest-news/author/admin/page/6) [7](https://hemostemix.com/latest-news/author/admin/page/7) [![LOGO\_Primary](https://hemostemix.com/hubfs/LOGO_Primary.png)](https://hemostemix.com) Leave us a message Follow Us Copyright © 2026 Hemostemix, Inc [Privacy Policy |](https://hemostemix.com/privacy-policy) [Terms of Service](https://hemostemix.com/sms-terms-of-service)